Maturation of monocyte-derived dendritic cells by Hochu-ekki-to, a traditional Japanese herbal medicine

International Immunopharmacology

Volumn 4, Issue 1, 2004, Pages 37-45

  Nabeshima, Shigeki ^a   Murata, Masayuki ^a   Hamada, Maki ^a   Chong, Yong ^a   Yamaji, Kouzaburo ^a   Hayashi, Jun ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Antigen presentation; Dendritic cell; Herbal medicine; Hochu ekki to; LPS; Maturation; TNF

Indexed keywords

ALBUMIN; B7 ANTIGEN; BU ZHONG YI QI TANG; CD83 ANTIGEN; CD86 ANTIGEN; CELL MARKER; FLUORESCEIN ISOTHIOCYANATE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL CULTURE; CELL LABELING; CELL MATURATION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOSE RESPONSE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HERBAL MEDICINE; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; UPREGULATION; VOLUNTEER;

EID: 1242329084     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2003.10.002     Document Type: Article

References (32)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
2. Banchereau J., Paczesny S., Blanco P.et al. Dendritic cells: controllers of the immune system and a new promise for immunotherapy. Ann. N. Y. Acad. Sci. 987:2003;180-187.
3. Richards J., Le Naour F., Hanash S., Beretta L. Integrated genomic and proteomic analysis of signaling pathways in dendritic cell differentiation and maturation. Ann. N. Y. Acad. Sci. 975:2002;91-100.
4. Li X.Y., Takimoto H., Miura S., Yoshikai Y., Matsuzaki G., Nomoto K. Effect of a traditional Chinese medicine, bu-zhong-yi-qi-tang (Japanese name: Hochu-ekki-to) on the protection against Listeria monocytogenes infection in mice. Immunopharmacol. Immunotoxicol. 14:1992;383-402.
5. Yamaoka Y., Kawakita T., Nomoto K. Protective effect of a traditional Japanese medicine Hochu-ekki-to (Chinese name: Bu-zhong-yi-qi-tang), on the susceptibility against Listeria monocytogenes in infant mice. Int. Immunopharmacol. 1:2001;1669-1677.
6. Yan X., Kita M., Minami M.et al. Antibacterial effect of kampo herbal formulation Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang) on Helicobacter pylori infection in mice. Microbiol. Immunol. 46:2002;475-482.
7. Mori K., Kido T., Daikuhara H.et al. Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the survival of mice infected with influenza virus. Antiviral. Res. 44:1999;103-111.
8. Abe S., Tansho S., Ishibashi H., Akagawa G., Komatsu Y., Yamaguchi H. Protection of immunosuppressed mice from lethal Candida infection by oral administration of a kampo medicine, Hochu-ekki-to. Immunopharmacol. Immunotoxicol. 21:1999;331-342.
9. Hossain M.S., Takimoto H., Hamano S.et al. Protective effects of Hochu-ekki-to, a Chinese traditional herbal medicine against murine cytomegalovirus infection. Immunopharmacology. 41:1999;169-181.
10. Itoh T., Itoh H., Kikuchi T. Five cases of MRSA-infected patients with cerebrovascular disorder and in a bedridden condition, for whom Bu-zhong-yi-qi-tang (Hochu-ekki-to) was useful. Am. J. Chin. Med. 28:2000;401-408.
11. Harada M., Seta K., Ito O.et al. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang). Immunopharmacol. Immunotoxicol. 17:1995;687-703.
12. Utsuyama M., Seidlar H., Kitagawa M., Hirokawa K. Immunological restoration and anti-tumor effect by Japanese herbal medicine in aged mice. Mech. Ageing. Dev. 122:2001;341-352.
13. Romani N., Gruner S., Brang D.et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:1994;83-93.
14. Bender A., Sapp M., Schuler G., Steinman R.M., Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods. 196:1996;121-135.
15. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:1995;389-400.
16. Nijman H.W., Kleijmeer M.J., Ossevoort M.A.et al. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. J. Exp. Med. 182:1995;163-174.
17. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor alpha. J. Exp. Med. 179:1994;1109-1118.
18. Trinchieri G., Scott P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Immunol. Res. 146:1995;423-431.
19. Cho J.M., Sato N., Kikuchi K. Prophylactic anti-tumor effect of Hochu-ekki-to (TJ41) by enhancing natural killer cell activity. In Vivo. 5:1991;389-391.
20. Kaneko M., Kishihara K., Kawakita T., Nakamura T., Takimoto H., Nomoto K. Suppression of IgE production in mice treated with a traditional Chinese medicine, Bu-zhong-yi-qi-tang (Japanese name: Hochu-ekki-to). Immunopharmacology. 36:1997;79-85.
21. Kaneko M., Kawakita T., Nomoto K. Inhibition of eosinophil infiltration into the mouse peritoneal cavity by a traditional Chinese medicine, Bu-zhong-yi-qi-tang (Japanese name: Hochu-ekki-to). Immunopharmacol. Immunotoxicol. 21:1999;125-140.
22. Kaneko M., Kawakita T., Yamaoka Y., Nomoto K. Development of the susceptibility to oral tolerance induction in infant mice administered a herbal drug, Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang). Int. Immunopharmacol. 1:2001;219-227.
23. Nakada T., Watanabe K., Matsumoto T., Santa K., Triizuka K., Hanawa T. Effect of orally administered Hochu-ekki-to, a Japanese herbal medicine, on contact hypersensitivity caused by repeated application of antigen. Int. Immunopharmacol. 2:2002;901-911.
24. Liu Y.J., Kanzler H., Soumelis V., Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2:2001;585-589.
25. Terawaki K., Nose M., Ogihara Y. The effects of crude polysaccharide fractions of 4 kinds of kampo-hozai administered orally on nitric oxide production by murine peritoneal macrophages. Biol. Pharm. Bull. 20:1997;809-811.
26. Nose M., Terawaki K., Oguri K., Ogihara Y., Yoshimatsu K., Shimomura K. Activation of macrophages by crude polysaccharide fractions obtained from shoots of Glycyrrhiza glabra and hairy roots of Glycyrrhiza uralensis in vitro. Biol. Pharm. Bull. 21:1998;1110-1112.
27. Makino M., Shimokubo S., Wakamatsu S.I., Izumo S., Baba M. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J. Virol. 73:1999;4575-4581.
28. Beckebaum S., Cicinnati V.R., Zhang X.et al. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology. 109:2003;487-495.
29. Fowler N.L., Torresi J., Jackson D.C., Brown L.E., Gowans E.J. Immune responses in hepatitis C virus infection: the role of dendritic cells. Immunol. Cell Biol. 81:2003;63-66.
30. Sher A., Pearce E., Kaye P. Shaping the immune response to parasites: role of dendritic cells. Curr. Opin. Immunol. 15:2003;421-429.
31. Uyemura K., Castle S.C., Makinodan T. The frail elderly: role of dendritic cells in the susceptibility of infection. Mech. Ageing. Dev. 123:2002;955-962.
32. Berger T.G., Schultz E.S. Dendritic cell-based immunotherapy. Curr. Top. Microbiol. Immunol. 276:2003;163-197.